Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
2.
Zootaxa ; 5175(4): 463-477, 2022 Aug 18.
Artículo en Inglés | MEDLINE | ID: mdl-36095351

RESUMEN

A new species Andropromachus ynau sp. nov.. is described and the Chinese species of the moss-like stick insect genus Andropromachus are reviewed. An updated key to the known species of this genus is provided. Types of the new species are deposited in Yunnan Agricultural University (YNAU).


Asunto(s)
Briófitas , Neoptera , Animales , China , Humanos , Insectos , Universidades
3.
Nanomaterials (Basel) ; 6(10)2016 Oct 13.
Artículo en Inglés | MEDLINE | ID: mdl-28335311

RESUMEN

This work presents mixed (FAPbI3)1-x(MAPbBr3)x perovskite films with various composition ratios, x (x = 0-1), which are formed using the spin coating method. The structural, optical, and electronic behaviors of the mixed (FAPbI3)1-x(MAPbBr3)x perovskite films are discussed. A device with structure glass/indium tin oxide (ITO)/poly(3,4-ethylenedioxythiophene) polystyrene sulfonate (PEDOT:PSS)/mixed perovskite/C60/BCP/Ag was fabricated. The mixed perovskite film was an active light-harvesting layer. PEDOT: PSS was a hole transporting layer between the ITO and perovskite. Both C60 and bathocuproine (BCP) were electron transporting layers. MAPbBr3 was added to FAPbI3 with a composition ratio of x = 0.2, stabilizing the perovskite phase, which exhibited a uniform and dense morphology. The optimal device exhibited band matching with C60, resulting in a low series resistance (Rsh) and a high fill factor (FF). Therefore, the device with composition (FAPbI3)1-x(MAPbBr3)x and x = 0.2 exhibited outstanding performance.

4.
Materials (Basel) ; 9(9)2016 Sep 03.
Artículo en Inglés | MEDLINE | ID: mdl-28773874

RESUMEN

This study determines the effects of annealing treatment on the structure and the optical and electronic behaviors of the mixed (FAPbI3)1-x(MAPbBr3)x perovskite system. The experimental results reveal that (FAPbI3)1-x(MAPbBr3)x (x ~ 0.2) is an effective light-absorbing material for use in inverted planar perovskite solar cells owing to its large absorbance and tunable band gap. Therefore, good band-matching between the (FAPbI3)1-x(MAPbBr3)x and C60 in photovoltaic devices can be controlled by annealing at various temperatures. Accordingly, an inverted mixed perovskite solar cell with a record efficiency of 12.0% under AM1.5G irradiation is realized.

5.
J Clin Lipidol ; 9(2): 234-40, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25911080

RESUMEN

BACKGROUND: Clinical observation and treatment of children with homozygous familial hypercholesterolemia (HoFH) has rarely been reported. We report clinical observations and treatment of 10 ethnic Chinese children with HoFH due to low-density lipoprotein receptor (LDLR) defect. OBJECTIVES: In children with HoFH, we evaluated the response to conventional cholesterol-lowering drug therapy and performed LDLR gene analysis. METHODS: A retrospective review of lipid profile changes in pediatric patients diagnosed with HoFH seen in our pediatric endocrinology outpatient clinic was performed. HoFH was diagnosed by molecular study of these patients and their parents. RESULTS: One novel (c.64del G) and 12 known mutations were found in the LDLR gene. Mutation of p.C308Y was the most common and was found in 26% of the studied alleles.Seven patients had fair responses to conventional drug therapy (high-dose statin with ezetimibe) with a reduction of 50% or more of the total cholesterol levels. The low-density lipoprotein-cholesterol levels of three patients decreased to lower than 160 mg/dL. One who had a good response to conventional drug therapy developed significant atheromatous plaques (largest plaque: 7.4 × 2.7 cm) in the extracranial carotid arteries and myocardial ischemia changes at 11 years old. CONCLUSION: The results suggest that despite aggressive therapy, many patients are not well controlled; atherosclerosis may progress, and novel therapies are required.


Asunto(s)
Aterosclerosis/tratamiento farmacológico , Hiperlipoproteinemia Tipo II/tratamiento farmacológico , Hiperlipoproteinemia Tipo II/genética , Receptores de LDL/genética , Adolescente , Adulto , Aterosclerosis/sangre , Aterosclerosis/genética , Aterosclerosis/patología , Niño , Preescolar , Ezetimiba/administración & dosificación , Femenino , Homocigoto , Humanos , Inhibidores de Hidroximetilglutaril-CoA Reductasas/administración & dosificación , Hiperlipoproteinemia Tipo II/sangre , Hiperlipoproteinemia Tipo II/patología , Lípidos/sangre , Masculino , Mutación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...